BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24258996)

  • 21. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
    de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
    Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
    Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
    Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the stem cell marker nestin in peripheral blood of patients with melanoma.
    Fusi A; Ochsenreither S; Busse A; Rietz A; Keilholz U
    Br J Dermatol; 2010 Jul; 163(1):107-14. PubMed ID: 20346020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.
    Koyanagi K; Mori T; O'Day SJ; Martinez SR; Wang HJ; Hoon DS
    Cancer Res; 2006 Jun; 66(12):6111-7. PubMed ID: 16778184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
    de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
    Palmieri G; Satriano SM; Budroni M; Cossu A; Tanda F; Canzanella S; Caracò C; Simeone E; Daponte A; Mozzillo N; Comella G; Castello G; Ascierto PA
    BMC Cancer; 2006 Nov; 6():266. PubMed ID: 17107608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
    Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
    Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
    J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of the RT-PCR technique to detect melanoma cells in peripheral blood.
    Suárez A; Fra J; Alonso R; Sánchez R; Lacave AJ; Gutiérrez C
    Anticancer Res; 2002; 22(2B):1091-5. PubMed ID: 12168906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.
    Mellado B; Colomer D; Castel T; Muñoz M; Carballo E; Galán M; Mascaró JM; Vives-Corrons JL; Grau JJ; Estapé J
    J Clin Oncol; 1996 Jul; 14(7):2091-7. PubMed ID: 8683241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.
    Hoon DS; Bostick P; Kuo C; Okamoto T; Wang HJ; Elashoff R; Morton DL
    Cancer Res; 2000 Apr; 60(8):2253-7. PubMed ID: 10786692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple RT-PCR markers for the detection of circulating tumour cells of metastatic canine mammary tumours.
    da Costa A; Kohn B; Gruber AD; Klopfleisch R
    Vet J; 2013 Apr; 196(1):34-9. PubMed ID: 23036177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients.
    Schittek B; Blaheta HJ; Ellwanger U; Garbe C
    Recent Results Cancer Res; 2001; 158():93-104. PubMed ID: 11092036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
    Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.